GRC Quote, Financials, Valuation and Earnings

Omega Flex has a net margin of 7.68% compared to Gorman-Rupp's net margin of 18.56%. Gorman-Rupp's return on equity of 10.73% beat Omega Flex's return on equity of 22.86%.

Gorman-Rupp has a consensus price target of --, signalling upside risk potential of 42.47%. On the other hand Omega Flex has an analysts' consensus of -- which suggests that it could fall by --. Given that Gorman-Rupp has higher upside potential than Omega Flex, analysts believe Gorman-Rupp is more attractive than Omega Flex.

Gorman-Rupp has a beta of 0.971, which suggesting that the stock is 2.876% less volatile than S&P 500. In comparison Omega Flex has a beta of 0.386, suggesting its less volatile than the S&P 500 by 61.373%.

Gorman-Rupp has a quarterly dividend of $0.19 per share corresponding to a yield of 1.95%. Omega Flex offers a yield of 3.5% to investors and pays a quarterly dividend of $0.34 per share. Gorman-Rupp pays 52.78% of its earnings as a dividend. Omega Flex pays out 63.21% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Gorman-Rupp quarterly revenues are $168.2M, which are larger than Omega Flex quarterly revenues of $24.9M. Gorman-Rupp's net income of $12.9M is higher than Omega Flex's net income of $4.6M. Notably, Gorman-Rupp's price-to-earnings ratio is 25.66x while Omega Flex's PE ratio is 21.18x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Gorman-Rupp is 1.48x versus 3.78x for Omega Flex. Usually stocks with elevated PS ratios are considered overvalued.

Smith & Wesson Brands has a net margin of 7.68% compared to Gorman-Rupp's net margin of 3.19%. Gorman-Rupp's return on equity of 10.73% beat Smith & Wesson Brands's return on equity of 9.5%.

Gorman-Rupp has a consensus price target of --, signalling upside risk potential of 42.47%. On the other hand Smith & Wesson Brands has an analysts' consensus of $15.33 which suggests that it could grow by 54.57%. Given that Smith & Wesson Brands has higher upside potential than Gorman-Rupp, analysts believe Smith & Wesson Brands is more attractive than Gorman-Rupp.

Gorman-Rupp has a beta of 0.971, which suggesting that the stock is 2.876% less volatile than S&P 500. In comparison Smith & Wesson Brands has a beta of 1.025, suggesting its more volatile than the S&P 500 by 2.504%.

Gorman-Rupp has a quarterly dividend of $0.19 per share corresponding to a yield of 1.95%. Smith & Wesson Brands offers a yield of 5.14% to investors and pays a quarterly dividend of $0.13 per share. Gorman-Rupp pays 52.78% of its earnings as a dividend. Smith & Wesson Brands pays out 55.59% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Gorman-Rupp quarterly revenues are $168.2M, which are larger than Smith & Wesson Brands quarterly revenues of $129.7M. Gorman-Rupp's net income of $12.9M is higher than Smith & Wesson Brands's net income of $4.1M. Notably, Gorman-Rupp's price-to-earnings ratio is 25.66x while Smith & Wesson Brands's PE ratio is 12.72x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Gorman-Rupp is 1.48x versus 0.88x for Smith & Wesson Brands. Usually stocks with elevated PS ratios are considered overvalued.

Standex International has a net margin of 7.68% compared to Gorman-Rupp's net margin of 10.68%. Gorman-Rupp's return on equity of 10.73% beat Standex International's return on equity of 11.64%.

Gorman-Rupp has a consensus price target of --, signalling upside risk potential of 42.47%. On the other hand Standex International has an analysts' consensus of -- which suggests that it could grow by 18.32%. Given that Gorman-Rupp has higher upside potential than Standex International, analysts believe Gorman-Rupp is more attractive than Standex International.

Gorman-Rupp has a beta of 0.971, which suggesting that the stock is 2.876% less volatile than S&P 500. In comparison Standex International has a beta of 1.068, suggesting its more volatile than the S&P 500 by 6.806%.

Gorman-Rupp has a quarterly dividend of $0.19 per share corresponding to a yield of 1.95%. Standex International offers a yield of 0.66% to investors and pays a quarterly dividend of $0.32 per share. Gorman-Rupp pays 52.78% of its earnings as a dividend. Standex International pays out 19.03% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Gorman-Rupp quarterly revenues are $168.2M, which are smaller than Standex International quarterly revenues of $170.5M. Gorman-Rupp's net income of $12.9M is lower than Standex International's net income of $18.2M. Notably, Gorman-Rupp's price-to-earnings ratio is 25.66x while Standex International's PE ratio is 30.19x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Gorman-Rupp is 1.48x versus 3.10x for Standex International. Usually stocks with elevated PS ratios are considered overvalued.

Xylem has a net margin of 7.68% compared to Gorman-Rupp's net margin of 10.31%. Gorman-Rupp's return on equity of 10.73% beat Xylem's return on equity of 8.1%.

Gorman-Rupp has a consensus price target of --, signalling upside risk potential of 42.47%. On the other hand Xylem has an analysts' consensus of $146.95 which suggests that it could grow by 26.78%. Given that Gorman-Rupp has higher upside potential than Xylem, analysts believe Gorman-Rupp is more attractive than Xylem.

Gorman-Rupp has a beta of 0.971, which suggesting that the stock is 2.876% less volatile than S&P 500. In comparison Xylem has a beta of 1.065, suggesting its more volatile than the S&P 500 by 6.481%.

Gorman-Rupp has a quarterly dividend of $0.19 per share corresponding to a yield of 1.95%. Xylem offers a yield of 1.24% to investors and pays a quarterly dividend of $0.36 per share. Gorman-Rupp pays 52.78% of its earnings as a dividend. Xylem pays out 49.1% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Gorman-Rupp quarterly revenues are $168.2M, which are smaller than Xylem quarterly revenues of $2.1B. Gorman-Rupp's net income of $12.9M is lower than Xylem's net income of $217M. Notably, Gorman-Rupp's price-to-earnings ratio is 25.66x while Xylem's PE ratio is 33.31x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Gorman-Rupp is 1.48x versus 3.35x for Xylem. Usually stocks with elevated PS ratios are considered overvalued.